1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Montefusco, V., Corso, A., Galli, M., Ardoino, I., Pezzatti, S., Carniti, C., Patriarca, F., Gherlinzoni, F., Zambello, R., Sammassimo, S., Marcatti, M., Nozza, A., Crippa, C., Cafro, A. M., Baldini, L. & Corradini, P., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Montefusco, V., Corso, A., Galli, M., Ardoino, I., Pezzatti, S., Carniti, C., Patriarca, F., Gherlinzoni, F., Zambello, R., Sammassimo, S., Marcatti, M., Nozza, A., Crippa, C., Cafro, A. M., Baldini, L. & Corradini, P., 2020, In : British Journal of Haematology. 188, 6, p. 907-917 11 p.

Research output: Contribution to journalArticle

2019

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Feb 2019, In : Annals of Hematology. 98, 2, p. 361-367 7 p.

Research output: Contribution to journalArticle

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

Girmenia, C., Cavo, M., Offidani, M., Scaglione, F., Corso, A., Di Raimondo, F., Musto, P., Petrucci, M. T. & Barosi, G., Jan 1 2019, (Accepted/In press) In : Blood Reviews.

Research output: Contribution to journalArticle

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

Girmenia, C., Cavo, M., Offidani, M., Scaglione, F., Corso, A., Di Raimondo, F., Musto, P., Petrucci, M. T. & Barosi, G., Mar 2019, In : Blood Reviews. 34, p. 84-94 11 p.

Research output: Contribution to journalReview article

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice

Cocito, F., Mangiacavalli, S., Valeria Ferretti, V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice: Leukemia and Lymphoma

Cocito, F., Mangiacavalli, S., Ferretti, V. V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., 2019, In : Leuk. Lymphoma. 60, 12, p. 2968-2974 7 p.

Research output: Contribution to journalArticle

2018

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Oct 23 2018, In : Annals of Hematology.

Research output: Contribution to journalArticle

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D’Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Jan 1 2018, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

EMMOS Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

The advantages of switch to subcutaneous bortezomib in the real life

Mangiacavalli, S., Cocito, F., Ferretti, V. V., Ganzetti, M., Cartia, C. S. & Corso, A., Jun 2018, In : Leukemia and Lymphoma. 59, 6, p. 1505-1507 3 p.

Research output: Contribution to journalArticle

2017

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Mar 1 2017, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Bahlis, N. J., Corso, A., Mugge, L. O., Shen, Z. X., Desjardins, P., Stoppa, A. M., Decaux, O., De Revel, T., Granell, M., Marit, G., Nahi, H., Demuynck, H., Huang, S. Y., Basu, S., Guthrie, T. H., Ervin-Haynes, A., Marek, J., Chen, G. & Facon, T., Nov 1 2017, In : Leukemia. 31, 11, p. 2435-2442 8 p.

Research output: Contribution to journalArticle

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., Apr 13 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

2016

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, G. A. & Morabito, F., Dec 6 2016, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice

Jurczyszyn, A., Grzasko, N., Gozzetti, A., Czepiel, J., Cerase, A., Hungria, V., Crusoe, E., Silva Dias, A. L. M., Vij, R., Fiala, M. A., Caers, J., Rasche, L., Nooka, A. K., Lonial, S., Vesole, D. H., Philip, S., Gangatharan, S., Druzd-Sitek, A., Walewski, J., Corso, A. & 31 others, Cocito, F., Vekemans, M. C. M., Atilla, E., Beksac, M., Leleu, X., Davila, J., Badros, A., Aneja, E., Abildgaard, N., Kastritis, E., Fantl, D., Schutz, N., Pika, T., Butrym, A., Olszewska-Szopa, M., Usnarska-Zubkiewicz, L., Usmani, S. Z., Nahi, H., Chim, C. S., Shustik, C., Madry, K., Lentzsch, S., Swiderska, A., Helbig, G., Guzicka-Kazimierczak, R., Lendvai, N., Waage, A., Andersen, K. T., Murakami, H., Zweegman, S. & Castillo, J. J., Jun 1 2016, In : American Journal of Hematology. 91, 6, p. 575-580 6 p.

Research output: Contribution to journalArticle

Implemented myeloma management with whole-body low-dose CT scan: a real life experience

Mangiacavalli, S., Pezzatti, S., Rossini, F., Doni, E., Cocito, F., Bolis, S. & Corso, A., Jan 20 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Oct 21 2016, (Accepted/In press) In : Annals of Hematology. p. 1-8 8 p.

Research output: Contribution to journalArticle

2015

Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study

Oriol, A., Giraldo, P., Kotsianidis, I., Couturier, C., Olie, R., Angermund, R. & Corso, A., Aug 1 2015, In : Hematology. 20, 7, p. 405-409 5 p.

Research output: Contribution to journalArticle

Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM)

Zacchino, M., Bonaffini, P. A., Corso, A., Minetti, V., Nasatti, A., Tinelli, C., Dore, R., Calliada, F. & Sironi, S., Nov 1 2015, In : European Radiology. 25, 11, p. 3382-3389 8 p.

Research output: Contribution to journalArticle

Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

Romano, A., Parrinello, N. L., Consoli, M. L., Marchionni, L., Forte, S., Conticello, C., Pompa, A., Corso, A., Milone, G., Di Raimondo, F. & Borrello, I., Nov 22 2015, In : Annals of Hematology. 94, 11, p. 1875-1883 9 p.

Research output: Contribution to journalArticle

2014

Correction: Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: A cost-effectiveness analysis (PLoS ONE)

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Jan 8 2014, In : PLoS One. 9, 1

Research output: Contribution to journalArticle

Psychological care of caregivers, nurses and physicians: a study of a new approach

Abeni, M. S., Magni, M., Conte, M., Mangiacavalli, S., Pochintesta, L., Vicenzi, G., Ferretti, V. V., Pompa, A., Cocito, F., Klersy, C. & Corso, A., Feb 1 2014, In : Cancer Medicine. 3, 1, p. 101-110 10 p.

Research output: Contribution to journalArticle

Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Sep 30 2013, In : PLoS One. 8, 9, e75047.

Research output: Contribution to journalArticle

Monoclonal gammopathy of undetermined significance: A new proposal of workup

Mangiacavalli, S., Cocito, F., Pochintesta, L., Pascutto, C., Ferretti, V., Varettoni, M., Zappasodi, P., Pompa, A., Landini, B., Cazzola, M. & Corso, A., Oct 2013, In : European Journal of Haematology. 91, 4, p. 356-360 5 p.

Research output: Contribution to journalArticle

2012

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jȩdrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 7 others, Yehuda, D. B., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C. & Dimopoulos, M. A., May 10 2012, In : New England Journal of Medicine. 366, 19, p. 1759-1769 11 p.

Research output: Contribution to journalArticle

Risk of second cancers in Waldenström macroglobulinemia

Varettoni, M., Tedeschi, A., Arcaini, L., Pascutto, C., Vismara, E., Orlandi, E., Ricci, F., Corso, A., Greco, A., Mangiacavalli, S., Lazzarino, M. & Morra, E., Feb 2012, In : Annals of Oncology. 23, 2, p. 411-415 5 p.

Research output: Contribution to journalArticle

Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma

Mangiacavalli, S., Albani, G., Caravita, T., Cocito, F., Pascutto, C., Zappasodi, P., Bringhen, S., Palumbo, A., Cazzola, M. & Corso, A., Mar 2012, In : Leukemia and Lymphoma. 53, 3, p. 514-515 2 p.

Research output: Contribution to journalArticle

2010

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Harousseau, J. L., Dimopoulos, M. A., Wang, M., Corso, A., Chen, C., Attal, M., Spencer, A., Yu, Z., Olesnyckyj, M., Zeldis, J. B., Knight, R. D. & Weber, D. M., Oct 2010, In : Haematologica. 95, 10, p. 1738-1744 7 p.

Research output: Contribution to journalArticle

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma

Corso, A., Barbarano, L., Mangiacavalli, S., Spriano, M., Alessandrino, E. P., Cafro, A. M., Pascutto, C., Varettoni, M., Bernasconi, P., Grillo, G., Carella, A. M., Montalbetti, L., Lazzarino, M. & Morra, E., Feb 2010, In : Leukemia and Lymphoma. 51, 2, p. 236-242 7 p.

Research output: Contribution to journalArticle

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: A single-center experience with 1400 patients

Varettoni, M., Corso, A., Cocito, F., Mangiacavalli, S., Pascutto, C., Zappasodi, P., Pica, G. & Lazzarino, M., Jul 2010, In : Medicine (United States). 89, 4, p. 211-216 6 p.

Research output: Contribution to journalArticle

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: A longitudinal study on 1003 consecutive patients

Varettoni, M., Corso, A., Pica, G., Mangiacavalli, S., Pascutto, C. & Lazzarino, M., Feb 2010, In : Annals of Oncology. 21, 2, p. 325-330 6 p.

Research output: Contribution to journalArticle

2009

A striking response to bortezomib in a patient with pleural localization of multiple myeloma

Mangiacavalli, S., Varettoni, M., Zappasodi, P., Pica, G., Lazzarino, M. & Corso, A., Apr 2009, In : Leukemia Research. 33, 4, p. 577-578 2 p.

Research output: Contribution to journalArticle